Good progress made up until the Covid-19 crisis. Work set to resume once lockdown restrictions have been eased. Read more
Update on a project led by the researchers at King’s College Hospital/King’s College London, funded by the AAT, April 2020 Read more
A project run by researchers at Great Ormond Street Hospital, London, funded by the AAT and its generous supporters Read more
Funds from Bloodwise, Cancer Research UK and the AAT, enable Professor Judith Marsh and colleagues to make a compelling argument. Read more
Adult Aplastic Anaemia patients registry funded by the AAT discovered some interesting findings Read more
Encouraging to see new compounds being tested in the treatment of aplastic anaemia, narrated by Dr Laura Jardine, Newcastle University Read more
Update from researchers in China, narrated by Laura Jardine, Newcastle University Read more
A final piece of news from the 23rd Annual Congress of the European Haematology Association on the use of Eculizumab in PNH Read more
News from the 23rd Annual Congress of the European Haematology Association on an exciting study taking place at the MD Anderson Cancer Centre in Texas Read more
More news from the 23rd Annual Congress of the European Haematology Association (EHA) in Stockholm. Here is the feedback on the use of Eltrombopag as a single agent Read more
Revolutionary discovery of treatment using T-regulatory cells Read more
Encouraging results from a study into the use of Eltrombopag show that extended use of the drug at a fixed dose could speed and improve patients' response rates Read more
Eculizumab has revolutionised the treatment of PNH, offering freedom from blood transfusion and independence to a large number of patients Read more
Stem cell transplant is a very feasible option in a good proportion of patients who might be elderly, but are otherwise fit and healthy Read more